Company to host conference call and webcast on Thursday, May 16th at 8:30am EDT LYON, France, May 2, 2024 EDAP TMS SA , the global leader in robotic energy-based therapies, today announced that.
Focal Therapy for Prostate Cancer Therapeutics Market by Type, by End User (Hospitals & Specialty Clinics, Cancer Treatment Centers), and by Region – Global Share and Forecast to 2033
LYON, France, April 23, 2024 - EDAP TMS SA , the global leader in robotic energy-based therapies, announced that final results from the HIFI Study, the largest clinical trial ever conducted comparing.
StockNews.com downgraded shares of Edap Tms (NASDAQ:EDAP – Free Report) from a hold rating to a sell rating in a research note issued to investors on Friday morning. Separately, HC Wainwright increased their price target on Edap Tms from $16.00 to $19.00 and gave the stock a buy rating in a research report on Monday, […]